[Congenital muscular dystrophies in children]

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Congenital muscular dystrophies (CMD) encompass a heterogeneous group of neuromuscular disorders.
• Key subtypes include merosin deficiency, collagen VI deficiency, LMNA-related, SEPN1-related, and alpha-dystroglycan-related CMD.
• These conditions often manifest in infancy with hypotonia and paresis, showing a characteristic dystrophic pattern on muscle biopsy.

Purpose of the Study:

• To review recent advancements in the classification of congenital muscular dystrophies.
• To correlate genetic findings with protein involvement and clinical presentations.
• To provide an updated overview of CMD subtypes.

Main Methods:

• Literature review of recent research on congenital muscular dystrophies.
• Analysis of genetic classifications and protein-associated subtypes.
• Correlation of molecular pathogenesis with clinical phenotypes.

Main Results:

• Significant progress has been made in classifying CMD subtypes based on genetic underpinnings.
• Understanding the molecular basis has refined diagnostic approaches.
• The spectrum of clinical presentations associated with different genetic forms is better defined.

Conclusions:

• Advances in molecular pathogenesis have led to improved classification of CMD.
• Genetics, protein involvement, and clinical presentation are key factors in understanding CMD subtypes.
• Continued research is crucial for further unraveling the complexities of these rare diseases.